γ-glutamyltransferase decreases in patients with the chronic form of schistosomiasis mansoni treated with ursodeoxycholic acid [3]

Journal of Clinical Pathology

Volumn 58, Issue 7, 2005, Pages 783-784

  Ribeiro, P De J ^a   Narciso, J L ^a   De Toledo, C F ^a   Borges, D R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; PROTHROMBIN; URSODEOXYCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ADULT; CHRONIC DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; PROSPECTIVE STUDIES; SCHISTOSOMIASIS MANSONI; URSODEOXYCHOLIC ACID;

EID: 21844465735     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Borges DR, Manoukian N, Toledo CF. Protein C deficiency in the compensated form of hepatosplenic schistosomiasis. Braz J Med Biol Res 1987;20:557-60.
2. Camacho-Lobato L, Borges DR. Early liver dysfunction in schistosomiasis. J Hepatol 1998;29:233-40.
3. Gammal SH, Borges DR, Maciel RMB, et al. High T4 syndrome in schistosomiasis [abstract]. Dig Dis Sci 1986;31:269S.
4. Köpke-Aguiar LA, Martins JRM, Passerotti CC, et al. Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis. Acta Trop 2002;84:117-26.
5. Amaral ACC, Köpke-Aguiar IA, Souza MRA, et al. Elevação da γ-glutamiltransferase sérica na hepatopatia esquistossomótica não se correlaciona com a carga parasitária e precede alterações ultra-sonográficas. Arq Gastroenterol 2002;39:27-31.
6. Martins RD, Borges DR. Ethanol challenge in non-alcoholic patients with schistosomiasis. J Clin Pathol 1993;46:250-3.
7. WHO Report. Ultrasound in schistosomiasis. A practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis- related morbidity, 2000, Report of a WHO expert committee. Geneva: World Health Organization (Report TDR/STR/SCH/00, 1), 2000.
8. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-31.
9. Pelletier G, Roulot D, Davion T, et al. Randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Hepatology 2003;37:887-92.
10. Vianna MR, Gayotto LC, Telma R, et al. Intrahepatic bile duct changes in human hepatosplenic schistosomiasis mansoni. Liver 1989;9:100-9.